International Patent: SINGLE DOMAIN ANTIBODY SPECIFICALLY BINDING TO STAT3, FUSION PROTEIN INCLUDING SAME, AND USE THEREOF

GENEVA, Sept. 24 -- GENEXINE, INC. filed a patent application (KR2025/016027) for “SINGLE DOMAIN ANTIBODY SPECIFICALLY BINDING TO STAT3, FUSION PROTEIN INCLUDING SAME, AND USE THEREOF”. With publication no. WO/2026/079930, here are the other details related to the patent application:

Kind: Correction of entry in Section I of the PCT Gazette [A8]

IPC: C07K 16/18

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....